We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One key word that was repeated over and over on Bausch Health’s fourth-quarter earnings call was “organic,” as management tried to convince investors that it is pivoting away from some old bad habits. But one analyst wasn’t buying it.